Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
- PMID: 9495606
- DOI: 10.1016/s0165-0327(97)00159-6
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
Abstract
Elevated pretreatment plasma free homovanillic acid (HVA) predicted acute response to neuroleptic treatment in patients with manic psychosis. These findings suggest that plasma HVA may be a useful predictor of a successful short-term response in manic as well as schizophrenic psychoses, and that elevated pre-synaptic dopaminergic release may play a role in more than one group of psychotic disorders.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
